1. Business

Vaccines Market Analysis By Key Players, Trends, Driving Factors, Segmentation, Regional Insights, Companies Profiled | Serum Institute of India, Pfizer etc.

Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

The Vaccines Market was valued at USD 61.04 billion in 2021 and is projected to grow USD 125.5 billion in 2028, at a CAGR of 10.85%

Vaccines, also known as immunizations, are a key component of primary health care.  Vaccines reduce the risks of contracting diseases by working with the body’s natural defenses system to build protection. According to the World Health Organization (WHO), vaccines currently prevent 2-3 million deaths every year from diseases such as tetanus, diphtheria, pertussis, measles, and influenza. Growing awareness and increasing investment by the government are boosting sales.

Get Sample Copy of Report@ https://extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/vaccines-market/18966?utm_source=Atish

KEY INDUSTRY PLAYERS

Prominent market players have focused on strengthening their market positions with several product offerings. For instance, GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Pfizer, Inc. (US), Sanofi SA (France), CSL Limited (Australia), Emergent BioSolutions, Inc. (US), Johnson & Johnson (US), AstraZeneca plc (UK), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic A/S (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo Company, Limited (Japan), Panacea Biotec, Ltd. (India), Biological E Limited (India), Bharat Biotech Ltd. (India), Novavax, Inc. (US), FSUE NPO Microgen (Russia), Sinovac Biotech, Ltd. (China), Incepta Vaccine Limited (Bangladesh), Valneva SE (France), VBI Vaccines (US), PT Bio Farma (Persero) (Indonesia), Inovio Pharmaceuticals, Inc. (US), Chongqing Zhifei Biological Products Co., Ltd. (China), and Indian Immunologicals Limited (India).

KEY INDUSTRY DEVELOPMENTS:

In October 2021, Pfizer received the US FDA Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for children from 5 to 11 years of age.

LIST OF KEY COMPANIES PROFILED:

GlaxoSmithKline plc.

Merck & Co., Inc.

Pfizer, Inc.

Sanofi

CSL Limited

Emergent BioSolutions, Inc.

Johnson & Johnson Services, Inc.

AstraZeneca

Serum Institute of India Pvt. Ltd.

Bavarian Nordic A/S

Mitsubishi Tanabe Pharma Corporation

Daiichi Sankyo Company, Limited

Panacea Biotec, Ltd.

Biological E Limited

Bharat Biotech Ltd.

Novavax, Inc.

FSUE NPO Microgen

Sinovac Biotech, Ltd.

Incepta Vaccine Limited

Valneva SE

VBI Vaccines

PT Bio Farma (Persero)

Inovio Pharmaceuticals, Inc.

Chongqing Zhifei Biological Products Co., Ltd.

Indian Immunologicals Limited

0

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe